Retatrutide

About Retatrutide

Retatrutide is an investigational peptide being studied for its activity at three metabolic hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and the glucagon receptor. Because it targets all three pathways, it is commonly described in research literature as a triple receptor agonist.

Research into retatrutide has focused on the roles these signalling pathways may play in areas including appetite regulation, energy balance, glucose and lipid metabolism, and body-weight regulation. Its combined GLP-1/GIP/glucagon receptor activity distinguishes it from compounds that target only one or two of these pathways.

Retatrutide remains an investigational compound.

Product

Retatrutide

Strength / size

30 mg

Compound type

Investigational peptide

Research classification

GLP-1 / GIP / glucagon receptor agonist

Intended use

Research use only